MENLO PARK, Calif., Oct. 2, 2019 /PRNewswire/ --

BILLERICA, Mass., Oct. 2, 2019 /PRNewswire/ -- Exogenesis Corporation announced today that it received premarket clearance of a 510(k) application by the US Food and Drug Administration (FDA) for the Exogenesis Hernia Mesh, an innovative implant intended for soft tissue repair. Exogenesis Hernia Mesh possesses a unique nanometer-level surface texture, enabling favor

FORT LAUDERDALE, Fla., Oct. 2, 2019 /PRNewswire/ -- CB Insights today named CarePredict to the inaugural

HOUSTON, Oct. 2, 2019 /PRNewswire/ -- Vivante Health, creators of the

NEW YORK, Oct. 2, 2019 /PRNewswire/ -- Lark Health, a chronic disease prevention and management platform, today announced it was named to CB Insight's inaugural

SEATTLE, Oct. 2, 2019 /PRNewswire/ --Dear Catalyst Biosciences, Inc. Shareholders:22NW, LP ("22NW" or "we") is one of the largest shareholders of Catalyst Biosciences, Inc (the "Company") (NASDAQ: CBIO) with ownership of approximately 6% of the Company's outstanding shares. As mentioned in our previous letter, we recommended shareholders apply pressure to t

LAS VEGAS, Oct. 2, 2019 /PRNewswire/ -- Remark Holdings, Inc. (NASDAQ: MARK), a diversified global technology company with leading artificial intelligence ("AI") solutions and digital media properties, today announced a new partnership with Tongyue Technologies to bring its KanKan AI school solutions and leading AI technology to Tongyue's recent launch of its Kindergarte

MAPLE GROVE, Minn., Oct. 2, 2019 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Tosymra™ (sumatriptan) Nasal

ROCKVILLE, Md., Oct. 2, 2019 /PRNewswire/ -- CNSI, a leading business solutions provider in developing and delivering innovative health information technology solutions, announced today that

WINDSOR, Conn., Oct. 2, 2019 /PRNewswire/ -- S